Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Emerging Treatments

Gain expert insights on investigational treatments currently in phase II/III trials for axial spondyloarthritis.
Atul Deodhar, MD
Program Director
M. Susan Burke, MD, FACP
Marina N. Magrey, MD
Released: July 30, 2020 Expiration: No longer available for credit

Related Content

Expert insights from ACR 2021, including the most important data to clinical practice on the management of axPsA and axSpA, from Clinical Care Options (CCO)

Philip Mease, MD, MACR Released: December 23, 2021

Expert insights from ACR 2021, including the most important data for clinical practice on the management of axSpA and axPsA, from Clinical Care Options (CCO)

Atul Deodhar, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Released: December 22, 2021 Expired: December 21, 2022

From Clinical Care Options (CCO), new data in managing axial psoriatic arthritis and axial spondyloarthritis from EULAR 2021

Atul Deodhar, MD Philip Mease, MD, MACR Physicians: maximum of 0.5 AMA PRA Category 1 Credits Released: September 2, 2021 Expired: September 1, 2022

Dr. Atul Deodhar discusses the latest clinically relevant data on drug-free remission in axSpA, MRI for axSpA diagnosis, vaccination for COVID-19 in patients with autoimmune inflammatory rheumatic diseases from Clinical Care Options (CCO).

Atul Deodhar, MD Released: August 26, 2021

Video Chapters


Provided by Purdue University College of Pharmacy
Purdue University Logo

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

This activity is supported by educational funding provided by
AbbVie Inc.
Novartis Pharmaceuticals Corporation

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings